Checkpoint Therapeutics

$2.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.17 (-7.20%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CKPT and other stocks, options, and ETFs commission-free!

About CKPT

Checkpoint Therapeutics, Inc. Common Stock, also called Checkpoint Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Read More Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY. The listed name for CKPT is Checkpoint Therapeutics, Inc. Common Stock.

CEO
James F. Oliviero
Employees
8
Headquarters
New York, New York
Founded
2014
Market Cap
147.52M
Price-Earnings Ratio
Dividend Yield
Average Volume
415.23K
High Today
$2.36
Low Today
$2.16
Open Price
$2.35
Volume
372.38K
52 Week High
$4.50
52 Week Low
$1.05

Collections

CKPT Earnings

-$0.27
-$0.18
-$0.09
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 13, After Hours

You May Also Like